- Short Report
- Open Access
Survival of Burkholderia pseudomallei in Water
© Moore et al; licensee BioMed Central Ltd. 2008
Received: 14 March 2008
Accepted: 7 May 2008
Published: 7 May 2008
The ability of Burkholderia pseudomallei to survive in water likely contributes to its environmental persistence in endemic regions. To determine the physiological adaptations which allow B. pseudomallei to survive in aqueous environments, we performed microarray analyses of B. pseudomallei cultures transferred from Luria broth (LB) to distilled water.
Increased expression of a gene encoding for a putative membrane protein (BPSL0721) was confirmed using a lux-based transcriptional reporter system, and maximal expression was noted at approximately 6 hrs after shifting cells from LB to water. A BPSL0721 deficient mutant of B. pseudomallei was able to survive in water for at least 90 days indicating that although involved, BPSL0721 was not essential for survival. BPSL2961, a gene encoding a putative phosphatidylglycerol phosphatase (PGP), was also induced when cells were shifted to water. This gene is likely involved in cell membrane biosynthesis. We were unable to construct a PGP mutant suggesting that the gene is not only involved in survival in water but is essential for cell viability. We also examined mutants of polyhydroxybutyrate synthase (phbC), lipopolysaccharide (LPS) oligosaccharide and capsule synthesis, and these mutations did not affect survival in water. LPS mutants lacking outer core were found to lose viability in water by 200 days indicating that an intact LPS core provides an outer membrane architecture which allows prolonged survival in water.
The results from these studies suggest that B. pseudomallei survival in water is a complex process that requires an LPS molecule which contains an intact core region.
Burkholderia pseudomallei is the causative agent of melioidosis, a disease endemic to southeast Asia, northern Australia and temperate areas that lie near the equator. The disease is classified by acute, subacute and chronic illnesses and often mistaken for malaria, plague, pneumonia and miliary tuberculosis . The acute form of the disease is a septicemic illness and is often fatal despite antibiotic treatment. Subacute meliodosis often results in multi-organ involvement, systemic abscess formation and bacteremia . Chronic meliodosis often is detected only after post mortem examination or by activation of other forms of the disease as a result of a traumatic event . Infection most likely occurs as a result of aspiration, inhalation or by exposure to contaminated soil or water [5, 6].
B. pseudomallei is able to survive in soils in endemic areas however recovery is dependent upon moisture content . Previous studies have demonstrated the ability of B. pseudomallei to survive in double distilled water for 3 years  and follow up studies on the same culture have shown that viable cells still exist after 17 years (Dr. Vanaporn Wuthiekanun, personal communication). Water supplies in Australia have been connected to meliododosis cases [9–11]illustrating the threat that long term survival in water may pose to water supplies.
While B. pseudomallei survival in water is well documented, the molecular mechanisms which allow B. pseudomallei to survive in water are poorly understood. In the present studies we examined a number of possible factors that may contribute to this survivability.
Bacterial strains and plasmids used in this study.
Strain or plasmid
Reference or source
E. coli TOP10
F-mcrA Δ(mrr-hsdRMS-mcrBC)Φ80lacZΔM15 ΔlacX74 deoR recA1 araΔ139 Δ(ara-leu)7697
S. aureus ATCC 13709
American Type Culture Collection
P. aeruginosa PAO1
American Type Culture Collection
Clinical isolate; Kmr Gmr Smr Pmr Tcs Tps
1026b derivative; allelic exchange strain; Δ(amrR-oprA) (Kms Gms Sms) rpsL (Smr)
DD503 derivative; ΔwcbB
DD503 derivative; waaE::dhfrIIb-p15AoriV; Zeor
1026b derivitive; wbiI::Tn5-OT182; Tcr
DD503 derivative; phaC::pGSV3-lux
DD503 derivative; BPSL0721::pGSV3-lux
Type strain genome sequence complete
American Type Culture Collection
Mobilizable suicide vector containing lux operon from Photorhabdus luminescens; OriT; Gmr
Topoisomerase-mediated cloning vector; Apr Kmr
Overnight cultures of bacteria were grown in 3 ml of LB in 15 ml plastic tubes. Cells were washed once in sterile distilled, deionized water and an aliquot added to 40 ml of sterile distilled, deionized water to a final concentration of approximately 106 colony forming units (CFU) per ml. Plate counts were performed immediately after the initial dilution and subsequently at various time points. All plate counts were done in duplicate using LB agar plates without antibiotics.
Mutagenesis of the B. pseudomallei poly (3)-hydroxybutyrate synthase gene (phbC or BPSL1534) and BPSL0721 was achieved using the lux-based suicide vector pGSV3-lux as previously described (Moore, et al., 2004). Briefly, a 549 bp internal region of the B. pseudomallei PHB synthase gene, phbC was PCR amplified using the primers GCACAAGACGTGGGACGAC (Forward) and ATGCGCGACAGATCGACGGG (Reverse). For BPSL0721, a 424 bp internal region was amplified using the primers TGTGGATGTCGCAGATGC (Forward) and ATGAAGCGGGTCTTCGACG (Reverse). The amplicons were cloned into pCR2.1-TOPO (Invitrogen) and subsequently excised with EcoR1 and cloned into EcoR1 digested, CIP treated, pGSV3-lux. The resulting plasmids, pGSV-lux-phbC and pGSV-lux-0721 were electroporated into E. coli SM10 λ pir and subsequently conjugated into B. pseudomallei DD503. Transconjugants were identified by selection on LB-Gm, PMB agar and tested for lux activity by screening for light production using 50–200 ul of an overnight culture in a SystemSure luminometer (Nova Biomedical, Waltham, MA). Integration of pGSV-lux-phbC into phbC and BPSL0721 was confirmed by PCR using a reverse primer internal to the luxC gene on the vector and a forward primer located at the 5' end of the phbC and BPSL0721 genes and upstream of the forward primers used to generate the internal fragments originally cloned into pGSV3-lux.
Transmission electron microscopy was performed on B. pseudomallei DD503 and the phbC mutant, RM330. One ml of cells was grown overnight in LB was centrifuged in a microcentrifuge. The supernatant was removed, and the cell pellet was subjected to a series of dehydration steps and finally cast in epoxy resin. Layers of the epoxy resin pellet were mounted on support grids and observed by transmission electron microscopy (University of Calgary Imaging Facility).
Microarray analysis was performed using a previously described low density DNA oligo-microarray . Total bacterial RNA was isolated from two 100 ml cultures grown overnight in LB. Cells were harvested by centrifugation and washed once with sterile water. Both pellets were resuspended in 100 ml of sterile water and one was treated immediately with RNAlater (Invitrogen), centrifuged and the cell pellet frozen. The remaining flask was allowed to shake at 37° for one hour at which time RNAlater was added, the cells centrifuged and the cell pellet frozen. Subsequently, cell pellets were thawed and RNA isolated as described previously .
Burkholderia pseudomallei genes up-regulated in water,
InfC, translational protein
putative cytochrome c-related lipoprotein
putative membrane protein
putative exported protein
glmU, bifunctional glmU protein [includes: UDP-N-acetylglucosamine pyrophosphorylase; glucosamine-1-phosphate N-acetyltransferase]
putative iron-sulphur protein
putative phage related protein (partial)
pdxA, 4-hydroxythreonine-4-phosphate dehydrogenase
dsbA, thioldisulfide interchange protein
kdsA, putative 2-dehydro-3-deoxyphosphooctonate aldolase
conserved hypothetical protein
putative ABC transport system, membrane protein
conserved hypothetical protein
BPSL2961, a gene encoding a putative phosphatidylglycerol phosphatase (PGP), was also induced when cells were shifted to water. This gene is likely involved in cell membrane biosynthesis (glycerophospholipid metabolism pathway). We were unable to construct a PGP mutant suggesting that the gene was not only involved in survival in water but is also essential for cell viability.
The role of LPS and capsule was examined by testing the ability of various mutants to survive in water. The mutants tested are shown in Table 1 and included a capsule mutant, an oligosaccharide deficient mutant, a double mutant lacking capsule and LPS oligosaccharide and a LPS core deficient mutant. Mutants lacking capsule, LPS oligosaccharide or both were not affected in their ability to survive in water. In contrast, a mutant lacking both oligosaccharide and LPS core died in water by 200 days indicating that intact core is required for long term survival of B. pseudomallei in water (Additional file 2).
A water environment presents unique challenges for the bacterial cell. Water lacks the nutrients found in other environments and provides an extreme hypo-osmotic condition. To survive for long periods of time the organism must be able to deal with the metabolic challenges resulting from lack of substrates normally used for maintenance and growth and must be able to adapt to low osmolarity. The fact that this environment requires special adaptations is illustrated by our observation that E. coli, S. aureus and notably, B. mallei, were unable to survive in this environment for prolonged periods.
A variety of factors contribute to the ability of B. pseudomallei to survive in the environment. These include a versatile metabolic capacity which allows the use of a variety of carbon sources for growth, the ability to live inside other microorganisms including protoza and fungi and the ability to tolerate a wide range of environmental conditions including a variety of soils and water environments such as those associated with rice farming and seasonal flooding. The ability of B. pseudomallei to survive in aqueous environments is a major factor in the survival and persistence of this organism in environments where meliodosis remains endemic.
We tested a number of hypotheses which we thought might contribute to B. pseudomallei survival in water. These included an examination of growth phase, PHB, capsule and LPS and the product of one gene that was shown to be up-regulated in water via microarray analysis. We examined cells grown in log and stationary phase hypothesizing that perhaps stationary phase cells had made the necessary modifications to the cell which would allow survival in water whereby cell in log phase had not. We found that cells taken from either growth phases were equally able to survive in water indicating that cell growth phase was not important or that the cells, in either log or stationary phase, must undergo some adaptation upon entering a water environment.
PHB has been shown to be involved in water survival in Legionella pneumophila  and would seem not unreasonable to play a role in water survival in B. pseudomallei. We found no significant loss in viability in a PHB deficient mutant, RM330, in water suggesting that in B. pseudomallei, PHB may not be critical as an energy source for long term survival. It is possible however, that PHB has an important role in other situations such as intracellular survival in protozoa and fungi and possibly human cells as well.
We found that B. pseudomallei capsule I was not required for survival in water. In contrast, capsule I is essential for B. pseudomallei virulence in hamsters where it serves to evade complement killing. That capsule is not solely required for water survival is further illustrated by the fact that B. mallei, which doesn't survive in water, expresses the same capsule as B. pseudomallei.
The mutant MB301, defective in core LPS oligosaccharide, showed a marked loss of viability by 200 days. This mutation also confers sensitivity to polymyxin B, a cationic antibiotic which is normally ineffective against B. pseudomallei at levels up to 100 mg/ml suggesting a loss of outer membrane integrity as a result of altered outer membrane architecture. LPS oligosaccharide is not essential for water survival suggesting that, like capsule, the molecule probably does little to help maintain the membrane integrity apparently required for long term water survival.
While this study identifies at least one component required for long term survival in water, it is probable that B. pseudomallei undergoes a number of other modifications which allow it to survive for years in nutrient poor, low osmolarity conditions. It is likely that membrane modifications occur as suggested by the up regulation of a putative phosphatidylglycerol phosphatase (BPSL2961). Further, energy metabolism is likely altered as indicated by the up-regulation of a putative cytochrome C related lipoprotein (BPSL1600) and a putative iron-sulfur protein (BPSL1615). In addition, the aqueous environment may trigger a number of cell signals that regulate the various modifications required for long term survival. Understanding how B. pseudomallei is able to survive in water may provide a better understanding of the organisms environmental persistence in endemic areas and may provide public health strategies for those living in these areas.
This work was funded by the Canadian Institutes of Health Research – MOP-36343. D.E.W. is a Canada Research Chair in Microbiology. We thank Dr. Jonathan Warawa for assistance in electron microscopy procedures.
- Chaowagul W, White NJ, Dance DA, Wattanagoon Y, Naigowit P, Davis TM, Looareesuwan S, Pitakwatchara N: Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis. 1989, 159: 890-899.View ArticlePubMedGoogle Scholar
- Dance DAB: Melioidosis: the tip of the iceberg?. Clinical Microbiology Reviews. 1991, 4: 52-60.PubMed CentralPubMedGoogle Scholar
- Smith C J.C. Allen, N.M. Embi, O. Othman, N. Razak, G. Ismail: Human melioidosis: an emergingmedical problem. MIRCEN Journal of applied Microbiology technology. 1987, 3: 3443-3366.Google Scholar
- Sanford JP: Pseudomonas species (including melioidosis and glanders). Principles and practiceof infectious diseases. Edited by: G. L. Mandell RGDJJEB. 1995, New York, New York, Churchhill LivingstoneGoogle Scholar
- Smith MD V. Wuthiekanun, A. L. Walsh, and N. J. White.: Quantitative discovery of Burkholderia pseudomallei from soil in Thailand. Trans R Soc Trop Med Hyg. 1995, 89: 488-490. 10.1016/0035-9203(95)90078-0.View ArticlePubMedGoogle Scholar
- Whitmore A C.S. Krishnaswami: An account of the discovery of a hitherto undescribed infective disease occurring amoung the population of Rangoon. Indian Medical Gazette. 1912, 47: 262-267.Google Scholar
- Wuthiekanun V, Smith MD, Dance DA, White NJ: Isolation of Pseudomonas pseudomallei from soil in north-eastern Thailand. Trans R Soc Trop Med Hyg. 1995, 89: 41-43. 10.1016/0035-9203(95)90651-7.View ArticlePubMedGoogle Scholar
- Wuthiekanun V, Smith MD, White NJ: Survival of Burkholderia pseudomallei in the absence of nutrients. Trans R Soc Trop Med Hyg. 1995, 89: 491-10.1016/0035-9203(95)90080-2.View ArticlePubMedGoogle Scholar
- Currie BJ, Mayo M, Anstey NM, Donohoe P, Haase A, Kemp DJ: A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates. Am J Trop Med Hyg. 2001, 65: 177-179.PubMedGoogle Scholar
- Inglis TJ, Garrow SC, Adams C, Henderson M, Mayo M, Currie BJ: Acute melioidosis outbreak in Western Australia. Epidemiol Infect. 1999, 123: 437-443. 10.1017/S0950268899002964.PubMed CentralView ArticlePubMedGoogle Scholar
- Inglis TJ, Garrow SC, Henderson M, Clair A, Sampson J, O'Reilly L, Cameron B: Burkholderia pseudomallei traced to water treatment plant in Australia. Emerg Infect Dis. 2000, 6: 56-59.PubMed CentralPubMedGoogle Scholar
- Moore RA, Reckseidler-Zenteno S, Kim H, Nierman W, Yu Y, Tuanyok A, Warawa J, DeShazer D, Woods DE: Contribution of gene loss to the pathogenic evolution of Burkholderia pseudomallei and Burkholderia mallei. Infect Immun. 2004, 72: 4172-4187. 10.1128/IAI.72.7.4172-4187.2004.PubMed CentralView ArticlePubMedGoogle Scholar
- James BW, Mauchline WS, Dennis PJ, Keevil CW, Wait R: Poly-3-hydroxybutyrate in Legionella pneumophila, an energy source for survival in low-nutrient environments. Appl Environ Microbiol. 1999, 65: 822-827.PubMed CentralPubMedGoogle Scholar
- Reckseidler SL, DeShazer D, Sokol PA, Woods DE: Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect Immun. 2001, 69: 34-44. 10.1128/IAI.69.1.34-44.2001.PubMed CentralView ArticlePubMedGoogle Scholar
- DeShazer D, Waag DM, Fritz DL, Woods DE: Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb Pathog. 2001, 30: 253-269. 10.1006/mpat.2000.0430.View ArticlePubMedGoogle Scholar
- DeShazer D, Brett PJ, Carlyon R, Woods DE: Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol. 1997, 179: 2116-2125.PubMed CentralPubMedGoogle Scholar
- Moore RA, DeShazer D, Reckseidler S, Weissman A, Woods DE: Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother. 1999, 43: 465-470.PubMed CentralPubMedGoogle Scholar
- Reckseidler-Zenteno SL, DeVinney R, Woods DE: The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition. Infect Immun. 2005, 73: 1106-1115. 10.1128/IAI.73.2.1106-1115.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Burtnick MN, Woods DE: Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother. 1999, 43: 2648-2656.PubMed CentralPubMedGoogle Scholar
- DeShazer D, Brett PJ, Woods DE: The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol Microbiol. 1998, 30: 1081-1100. 10.1046/j.1365-2958.1998.01139.x.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.